|
Volumn 46, Issue 4, 2011, Pages 197-200
|
[Effect of rapamycin combined with cisplatin on head and neck squamous cancer cells regulated by CCL19].
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIBIOTIC;
CCL19 PROTEIN, HUMAN;
CISPLATIN;
MACROPHAGE INFLAMMATORY PROTEIN 3BETA;
RAPAMYCIN;
APOPTOSIS;
ARTICLE;
CELL CYCLE;
CELL PROLIFERATION;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG POTENTIATION;
HEAD AND NECK TUMOR;
HUMAN;
PATHOLOGY;
SQUAMOUS CELL CARCINOMA;
TUMOR CELL LINE;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CARCINOMA, SQUAMOUS CELL;
CELL CYCLE;
CELL LINE, TUMOR;
CELL PROLIFERATION;
CHEMOKINE CCL19;
CISPLATIN;
DRUG SYNERGISM;
HEAD AND NECK NEOPLASMS;
HUMANS;
SIROLIMUS;
|
EID: 84906968295
PISSN: 10020098
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|